Chemomab Therapeutics Ltd. (CMMB)
1.75
-0.11
(-5.91%)
USD |
NASDAQ |
Jun 02, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics Total Liabilities (Quarterly) : 1.113M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioLineRx Ltd. | 17.96M |
| Kamada Ltd. | 123.63M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 2.845M |
| Entera Bio Ltd. | 2.442M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.81M |
| Shareholders Equity (Quarterly) | 10.70M |
| Current Ratio | 10.31 |
| Net Debt Paydown Yield | 0.57% |